NLRP3 and chronic obstructive pulmonary disease: Activation of PRRs (TLR2/4 and NLRP3) and purinergic receptors (P2X7R or P2Y2R) by DAMPs can provoke and enhance lung inflammation and remodeling as well as systemic inflammation, which might contribute to the development and progression of COPD.